SureTrader
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

G- The "law" is the APA, the "regulation"

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Biobillionair Member Profile
Member Level 
Followed By 70
Posts 11,367
Boards Moderated 0
Alias Born 01/12/13
160x600 placeholder
Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference Call on February 27th, 2018 GlobeNewswire Inc. - 2/20/2018 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/1/2018 5:02:21 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/31/2018 5:27:59 PM
Amarin Prices Public Offering of American Depositary Shares GlobeNewswire Inc. - 1/30/2018 8:58:26 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/29/2018 4:08:42 PM
Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire Inc. - 1/29/2018 4:01:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2018 6:01:14 PM
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark for Reported Primary Events GlobeNewswire Inc. - 1/23/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/17/2018 5:59:57 PM
Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China GlobeNewswire Inc. - 1/17/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 6:01:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 6:01:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2018 4:57:25 PM
Amarin Provides Preliminary 2017 Results and Provides 2018 Outlook GlobeNewswire Inc. - 1/4/2018 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2018 4:34:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2018 4:33:51 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 12/22/2017 4:13:13 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/21/2017 4:04:15 PM
Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018 GlobeNewswire Inc. - 12/19/2017 6:00:00 AM
Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco GlobeNewswire Inc. - 12/18/2017 4:30:00 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 12/4/2017 4:48:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/4/2017 9:04:12 AM
Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular ... GlobeNewswire Inc. - 11/14/2017 4:30:00 PM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Pat... GlobeNewswire Inc. - 11/13/2017 4:30:00 PM
Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical ... GlobeNewswire Inc. - 11/13/2017 6:00:00 AM
Biobillionair Member Level  Thursday, 10/05/17 06:38:48 PM
Re: HDGabor post# 115585
Post # of 122857 
G- The "law" is the APA, the "regulation" is the draft guidance related to SPA's and SPA communication, the evidence is the Ad Com video or transcript, you chose. For a bonus I can throw in law that regulates Ad Coms and case law that describes "arbitrary and capricious"....for example Judge Moss ruled the FDA would be arbitrary and capricious if the FDA would not rule on NCE. Instead the FDA was vindictive and delay NCE until last possible moment.

PS: I am the definition of vindictive, you can also find LB as a close second place followed by the third place going to Epi.

PSS: If you can't respond in an intelligent manner I suggest you try and insult me...again. You'll find my mental stability fairs quite well under significant pressure...this is my professional opinion.

PSSS: If Amarin loses ITC case and FDA doesn't take action against respondents, Amarin's attorney's will show you further law regarding APA, regulation, draft guidances, guidance, and ANCHOR damages, I promise. The last email I received from JT was clear Amarin stakeholders where going to be priority...then came ITC action.

BB


Mr. McGee, don't make me angry. You wouldn't like me when I'm angry---David Banner
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist